Melhores Teste de Sangue para Marcadores Tumorais médicos em Espanha - TOP-8 médicos

A specialist in the digestive system through MIR from the Hospital Clinic of Barcelona and a Doctor of Medicine from the University of Barcelona, he received his PhD from the University of Barcelona.

He completed his postgraduate training in the Gastroenterology Service of the Barcelona Hospital Clinic and then in the Department of Gastroenterology at Case Western Reserve University (Cleveland, USA), where he conducted cutting-edge research on inflammatory bowel diseases (IBD, Crohn's disease and ulcerative colitis).

From 2004 to 2011 he worked in the Gastroenterology Department of the Barcelona Hospital Clinic / IDIBAPS, and since 2011 he has worked as a specialist doctor in the Digestive System Department of the Teknon Medical Center in Barcelona.

He was a member of the Scientific Committee of ECCO and coordinator of the European project "IBDChip". He is the author of more than 150 publications and 500 presentations at conferences and conferences.

Experience:

Digestive system specialist, completed the MIR training program and completed his residency in this specialty at the Provincial Hospital of Barcelona between 1993 and 1996.

Doctor of Medicine from the University of Barcelona with the qualification "Distinguished Diploma Unanimously". In 2001 he received the Distinguished Doctorate from the University of Barcelona.

Between 1997 and 1999, he completed his postgraduate training in the Gastroenterology Department of the Provincial Hospital of Barcelona. Subsequently, he completed two internships in the Gastroenterology Department of Case Western Reserve University in Cleveland, USA, between 2000 and 2003, where he conducted cutting-edge research in the field of gastroenterology.

Since 2004 he has been working in the Gastroenterology Service of the Provincial Hospital of Barcelona / IDIBAPS, focusing on the treatment and research of inflammatory bowel diseases.

He is the author of numerous publications, conference papers and book chapters both nationally and internationally.

Member of the Catalan Society of Gastroenterology, the Spanish Association of Gastroenterology, the Spanish Working Group on Crohn's Disease and Ulcerative Colitis and the American Gastroenterological Association.

Areas of special interest: storage rhythm disorders, chronic diarrhea, inflammatory bowel diseases (Crohn's disease and ulcerative colitis) and other causes of chronic intestinal inflammation.

Head of the Department of Neurosurgery in the HM Hospitales Clinic

Dr. Blanca Lopez Ibor is an experienced specialist in children’s hematology and oncology from Spain. She is a lecturer at the Universidad Complutense de Madrid and Universidad CEU San Pablo, and is a consultant for the WHO and UNESCO. Dr Lopez Ibor has over 30 years of experience diagnosing and treating hematological and cancer disorders in children. She is also the head of two foundations that help children with severe health problems.

Dr. López-Ibor is a specialist in Pediatric Hematology and Oncology. She earned her medical degree from the Complutense University of Madrid and her doctorate from the University of Barcelona. She is also accredited by the University of Maryland. Dr. López-Ibor treats bone and brain tumors, leukemia, and blood disorders.

She has over 20 years of experience. Dr. López-Ibor leads the Pediatric Hematology and Oncology Unit at HM Montepríncipe Hospital. She has written many scientific articles, both nationally and internationally, and has made important contributions to her field.

Dr. Antonio Cubillo Gracián is a specialist in Medical Oncology. He has broad teaching and clinical experience at USP CEU and HM CIOCC. He has directed postgraduate research as Director of the Master’s in Clinical and Applied Research in Oncology. Since 2009, he has tutored more than 100 students, residents, and rotating staff.

Dr. Cubillo has advanced oncology education by teaching subjects such as General Medical Pathology, Oncology, Bioethics, and Pathophysiology. He has organized international courses on digestive neoplasms. He has also worked with leading institutions, including MD Anderson Cancer Center. His academic leadership and clinical mentorship have set high standards in oncology training and research.

Dr. Francesc Cobo Valien graduated from the Faculty of Medicine of the University of Barcelona in 1990.

He received his specialization in oncohematology at the Hospital Clínic de Barcelona in 1995. He combined medical practice and research activities in the period 1996-2002.

He received his Doctor of Medicine degree from the University of Barcelona in 2002.

Dr. Kobo continues his research and has been awarded grants:

•Interdepartmental Commission for Innovation of the Generalitat de Catalunya

•Scholarship Fund Universitaria Agustí Pedro i Pons

•Farreras Valentí & Schering Plough School of Hematology Scholarship

•Award for the best report at the Council of the Spanish Hematology Association

•Grant from the Catalan Society of Hematology

Specialization:

•Lymphoma

•Acute leukemia

•Chronic leukemia

•Autoimmune pancytopenia

Dr. Joseba Rebollo Liceaga is a seasoned medical oncologist with a comprehensive background in oncology.​

Education and Training:

Graduated in Medicine and Surgery from the University of Navarra (1985).​

Completed residency in Oncology in 1987.​

Specialist in Medical Oncology at the Clínica Universidad de Navarra (1991).​

Professional Experience:

Head of the Oncology Department at Clínica San Miguel de Navarra (1991–2004).​

Associate Physician at the University Clinic of the Faculty of Medicine, University of Navarra (1995–2002).​

Adjunct Physician at the Oncology Platform, Hospital Quirónsalud Torrevieja (2004–2014).

Head of the Oncology Department at Hospital General de Villalba (2014–2019).​

Currently practices as a Medical Oncology Specialist at Quirónsalud Alicante.​

Certifications and Training:

Completed multiple accredited courses in Multidisciplinary Oncology between 2003 and 2006.​

Research and Publications:

Authored research on electrochemotherapy and multidisciplinary treatment approaches in oncology.